2024 Q1 Form 10-Q Financial Statement

#000159169824000014 Filed on February 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $401.3M $326.4M
YoY Change 18.07% 19.54%
Cost Of Revenue $116.0M $107.4M
YoY Change 21.18% 19.23%
Gross Profit $285.3M $219.0M
YoY Change 16.86% 19.7%
Gross Profit Margin 71.1% 67.09%
Selling, General & Admin $135.6M $123.1M
YoY Change 11.68% -0.47%
% of Gross Profit 47.54% 56.23%
Research & Development $43.39M $46.14M
YoY Change 2.51% 12.45%
% of Gross Profit 15.21% 21.07%
Depreciation & Amortization $5.220M $5.179M
YoY Change 12.67% 13.1%
% of Gross Profit 1.83% 2.37%
Operating Expenses $179.0M $169.3M
YoY Change 9.31% 2.75%
Operating Profit $106.3M $49.71M
YoY Change 32.24% 172.99%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.324M $3.800M
YoY Change 279.63% -76100.0%
Pretax Income $110.6M $53.51M
YoY Change 35.69% 193.94%
Income Tax $25.30M $15.39M
% Of Pretax Income 22.87% 28.76%
Net Earnings $85.31M $38.12M
YoY Change 48.07% 144.33%
Net Earnings / Revenue 21.26% 11.68%
Basic Earnings Per Share $1.51 $0.68
Diluted Earnings Per Share $1.50 $0.67
COMMON SHARES
Basic Shares Outstanding 56.33M shares 56.18M shares
Diluted Shares Outstanding 57.05M shares 56.86M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $492.7M $366.9M
YoY Change 110.83% 205.62%
Cash & Equivalents $492.7M $366.9M
Short-Term Investments
Other Short-Term Assets $3.628B $3.320B
YoY Change 12.27% 7.25%
Inventory
Prepaid Expenses
Receivables $33.71M $32.48M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.247B $3.807B
YoY Change 19.08% 15.04%
LONG-TERM ASSETS
Property, Plant & Equipment $60.77M $63.15M
YoY Change 1.18% 6.12%
Goodwill $108.5M $109.6M
YoY Change 6.34% 7.35%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.56M $22.21M
YoY Change 8.25% -53.0%
Total Long-Term Assets $706.5M $686.0M
YoY Change 12.59% 9.11%
TOTAL ASSETS
Total Short-Term Assets $4.247B $3.807B
Total Long-Term Assets $706.5M $686.0M
Total Assets $4.953B $4.493B
YoY Change 18.11% 14.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.181M $7.973M
YoY Change -34.98% 4.76%
Accrued Expenses $170.6M $147.1M
YoY Change 18.22% 27.05%
Deferred Revenue $27.54M $30.31M
YoY Change 17.33% 28.75%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.765B $3.423B
YoY Change 12.24% 7.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.008M $4.177M
YoY Change 56.87% 25.32%
Total Long-Term Liabilities $6.008M $4.177M
YoY Change 56.87% 25.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.765B $3.423B
Total Long-Term Liabilities $6.008M $4.177M
Total Liabilities $3.854B $3.506B
YoY Change 12.52% 7.54%
SHAREHOLDERS EQUITY
Retained Earnings $624.6M $539.3M
YoY Change 45.46% 45.05%
Common Stock $56.00K $56.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.099B $986.8M
YoY Change
Total Liabilities & Shareholders Equity $4.953B $4.493B
YoY Change 18.11% 14.09%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $85.31M $38.12M
YoY Change 48.07% 144.33%
Depreciation, Depletion And Amortization $5.220M $5.179M
YoY Change 12.67% 13.1%
Cash From Operating Activities $167.5M $75.11M
YoY Change 31.55% 20.43%
INVESTING ACTIVITIES
Capital Expenditures $20.58M $18.03M
YoY Change 57.17% -238.62%
Acquisitions
YoY Change
Other Investing Activities $6.354M -$34.76M
YoY Change -104.14% 17.04%
Cash From Investing Activities -$14.22M -$52.79M
YoY Change -91.46% 23.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 297.6M 752.3M
YoY Change 125.62% -2.22%
NET CHANGE
Cash From Operating Activities 167.5M 75.11M
Cash From Investing Activities -14.22M -52.79M
Cash From Financing Activities 297.6M 752.3M
Net Change In Cash 450.9M 774.6M
YoY Change 386.51% -1.83%
FREE CASH FLOW
Cash From Operating Activities $167.5M $75.11M
Capital Expenditures $20.58M $18.03M
Free Cash Flow $147.0M $57.09M
YoY Change 28.61% -24.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
38381000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-21627000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
404980000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
288568000 usd
pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
74887000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-32585000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
330870000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366904000 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2759349000 usd
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55912000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55912000 shares
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8450000 usd
CY2022Q4 pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
5407000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
516000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
677767000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
892639000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48120000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
261000 usd
CY2023Q4 pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9534000 usd
CY2023Q4 pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
6826000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4929000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
38116000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
613463000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91124000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2941000 usd
pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8450000 usd
pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
82307000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1856000 usd
us-gaap Net Income Loss
NetIncomeLoss
45952000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
842863000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
92084000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
484000 usd
pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9534000 usd
pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
35874000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5049000 usd
us-gaap Net Income Loss
NetIncomeLoss
72633000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
986773000 usd
us-gaap Profit Loss
ProfitLoss
45952000 usd
us-gaap Profit Loss
ProfitLoss
72633000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
83364000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
82213000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29094000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35501000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-20856000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15225000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
602000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
463000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2039000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2683000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1410000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3870000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9377000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7052000 usd
pcty Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
40638000 usd
pcty Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
30743000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-616000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11328000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-392000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1131000 usd
pcty Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
-8979000 usd
pcty Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
-14278000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78757000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
137212000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
296060000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
164815000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
190253000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
150851000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
19740000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
29483000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6663000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6142000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12015000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-29000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
583000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132181000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62187000 usd
pcty Increase Decrease In Client Funds Obligation
IncreaseDecreaseInClientFundsObligation
922079000 usd
pcty Increase Decrease In Client Funds Obligation
IncreaseDecreaseInClientFundsObligation
-642416000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8450000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
9534000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
79369000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
35390000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-864000 usd
CY2023Q4 pcty Investments Accumulated Gross Unrealized Loss Before Tax
InvestmentsAccumulatedGrossUnrealizedLossBeforeTax
2477000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
13356000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-993862000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
629916000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1047286000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704941000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3793453000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2421312000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2746167000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3126253000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3422000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
117000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
382000 usd
us-gaap Interest Paid Net
InterestPaidNet
157000 usd
us-gaap Interest Paid Net
InterestPaidNet
247000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-158000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
25561000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120053000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366904000 usd
CY2022Q4 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2626114000 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2759349000 usd
CY2022Q4 pcty Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent
CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent
2746167000 usd
CY2023Q4 pcty Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent
CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent
3126253000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) Organization and Description of Business</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Paylocity Holding Corporation (the “Company”) is a cloud-based provider of human capital management and payroll software solutions that deliver a comprehensive platform for the modern workforce. Services are provided in a Software-as-a-Service (“SaaS”) delivery model. The Company’s comprehensive product suite delivers a unified platform that helps businesses attract and retain talent, build culture and connection with their employees, and streamline and automate HR and payroll processes.
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12233000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22617000 usd
CY2022Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12002000 usd
CY2023Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11588000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
20234000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
22232000 usd
CY2022Q4 pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
6460000 usd
pcty Period Of Term Arrangement
PeriodOfTermArrangement
P2Y
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256434000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
298416000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
501840000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
590101000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14195000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
24140000 usd
CY2023Q4 pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
9483000 usd
pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
12730000 usd
pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
18604000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19737000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26245000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19737000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26245000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P7Y
CY2022Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
308612000 usd
CY2022Q4 pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
39113000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-16855000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
330870000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
388226000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
372331000 usd
pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
74596000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-41947000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
404980000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
70999000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1620000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
463000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
314000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1769000 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
248738000 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
286103000 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
162611000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
182822000 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
86127000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
103281000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
141955000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
148110000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77886000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
84960000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64069000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63150000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
4579000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
5179000 usd
us-gaap Depreciation
Depreciation
9033000 usd
us-gaap Depreciation
Depreciation
10229000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
102054000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
7504000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
109558000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68569000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
71569000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
34042000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39103000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34527000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32466000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2770000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2525000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5541000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5061000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5182000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9488000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7869000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5493000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3629000 usd
CY2023Q4 pcty Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
805000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32466000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
85019000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66520000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7800000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8197000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24539000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30306000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25929000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42098000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143287000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
147121000 usd
CY2023Q2 pcty Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
288767000 usd
CY2023Q2 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288767000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Amortized Cost
FundsHeldForClientsCashAndCashEquivalentsAmortizedCost
2132545000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2132545000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
494741000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
45000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5916000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
488870000 usd
CY2023Q2 pcty Investments Amortized Cost
InvestmentsAmortizedCost
2916053000 usd
CY2023Q2 pcty Investments Accumulated Gross Unrealized Gain Before Tax
InvestmentsAccumulatedGrossUnrealizedGainBeforeTax
45000 usd
CY2023Q2 pcty Investments Accumulated Gross Unrealized Loss Before Tax
InvestmentsAccumulatedGrossUnrealizedLossBeforeTax
5916000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2023Q4 pcty Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
366904000 usd
CY2023Q4 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q4 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents Amortized Cost
FundsHeldForClientsCashAndCashEquivalentsAmortizedCost
2759349000 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
511388000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3476000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2477000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
512387000 usd
CY2023Q4 pcty Investments Amortized Cost
InvestmentsAmortizedCost
3637641000 usd
CY2023Q4 pcty Investments Accumulated Gross Unrealized Gain Before Tax
InvestmentsAccumulatedGrossUnrealizedGainBeforeTax
3476000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288767000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2132545000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
488870000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366904000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366904000 usd
CY2023Q2 us-gaap Funds Held For Clients
FundsHeldForClients
2621415000 usd
CY2023Q4 us-gaap Funds Held For Clients
FundsHeldForClients
3271736000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2023Q4 us-gaap Investments
Investments
3638640000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2305000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
344035000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3611000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
104818000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
5916000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
448853000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
268000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
165436000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2209000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
121001000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2477000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
286437000 usd
pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
CY2022Q4 pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
CY2023Q4 pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
214684000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
213663000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
152062000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
151098000 usd
CY2023Q4 pcty Available For Sale Securities Debt Maturities Two Years To Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsAmortizedCost
85613000 usd
CY2023Q4 pcty Available For Sale Securities Debt Maturities Two Years To Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsFairValue
86714000 usd
CY2023Q4 pcty Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year Three Through Five
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive
59029000 usd
CY2023Q4 pcty Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Three Through Five
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive
60912000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
511388000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
512387000 usd
CY2023Q4 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2759349000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
512387000 usd
CY2023Q4 us-gaap Investments
Investments
3638640000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43551000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43208000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83364000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
82213000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3154000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3916000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
6096000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
7965000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
72633000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55721000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56244000 shares
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
198250000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.143
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
CY2022Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.829
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15600000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38116000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
45952000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55587000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56140000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
753000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
611000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
972000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
766000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56474000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56855000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56559000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56906000 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
673000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
661000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32000 shares

Files In Submission

Name View Source Status
0001591698-24-000014-index-headers.html Edgar Link pending
0001591698-24-000014-index.html Edgar Link pending
0001591698-24-000014.txt Edgar Link pending
0001591698-24-000014-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcty-20231231.htm Edgar Link pending
pcty-20231231.xsd Edgar Link pending
pcty-20231231x10qex104.htm Edgar Link pending
pcty-20231231x10qex311.htm Edgar Link pending
pcty-20231231x10qex312.htm Edgar Link pending
pcty-20231231x10qex313.htm Edgar Link pending
pcty-20231231x10qex321.htm Edgar Link pending
pcty-20231231x10qex322.htm Edgar Link pending
pcty-20231231x10qex323.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
pcty-20231231_cal.xml Edgar Link unprocessable
pcty-20231231_def.xml Edgar Link unprocessable
pcty-20231231_lab.xml Edgar Link unprocessable
pcty-20231231_pre.xml Edgar Link unprocessable
pcty-20231231_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable